Stephen Liu
MD
Associate Professor of Medicine, Director of Thoracic Oncology and Director of Developmental Therapeutics
Georgetown Lombardi Comprehensive Cancer Center
Feb 11, 2025
Episode
260
Soundcloud
Share
In this episode of Lung Cancer Considered, host Dr. Stephen Liu moderates a Virtual Tumor Board case involving drug resistance in EGFR mutant NSCLC. This discussion takes the listener through the treatment of EGFR mutant NSCLC after acquired resistance to osimertinib.
Guest
Yasushi Goto
MD
National Cancer Center, Tokyo
Rachel Sanborn
MD
Earle A. Chiles Research Institute
Providence Cancer Institute
